Page 55 - Read Online
P. 55

Jabbari et al. Art Int Surg. 2025;5:200-9  https://dx.doi.org/10.20517/ais.2024.77       Page 204

               improve predictive models, as evidenced by the balanced bagging classifier with a F1 score of 0.80 and an
               AUC of 0.94. This model identified several important features, such as postoperative day 1 opioid use, body
               mass index, age, preoperative opioid use, prescribed opioids at discharge, and hospital length of stay. The
               identification of high-risk patients may guide clinical decisions and interventions.


               Another postoperative challenge specific to amputation patients is the development of pain or sensation
               that originates from the absent, amputated limb, known as PLP. Ortiz-Catalan et al. showed that motor
               execution of the phantom limb via ML, augmented and virtual reality, and gaming may hold potential as a
                               [42]
               treatment for PLP . Their cohort included fourteen patients with upper limb amputation and chronic
               intractable PLP. After the 12-session study period, a comparison of pre- and post-treatment PLP
               demonstrated significant decreases by 47% (P = 0.001) for weighted pain distribution, 32% (P = 0.007) for
               the numeric rating scale, and 51% (P = 0.0001) for the pain rating index. These findings further exemplify
               the potential role of AI applications in the evolution of treatment options for LLA patients.


               AI in lower extremity nerve injuries
               There is a need for innovative peripheral nerve injury strategies among LLA patients, as neurogenic pain
               secondary to hyperactive terminal neuroma formation is largely responsible for postoperative morbidity. In
               this effort, AI technologies can be used to understand the pathology of PNI and to better explore
               therapeutic approaches.


               Such an approach has led to the development of new research methods and strategies for nerve
               regeneration. Romeo-Guitart et al. showed the power of therapeutic performance mapping system (TPMS)
               technology for the design of drug therapies promoting nerve regeneration and functional recovery after
                   [43]
               PNI . TPMS develops mathematical models that simulate human physiology in silico, a process that is
               based  on  AI  and  pattern  recognition  models  that  source  all  available  biological,  medical,  and
               pharmacological knowledge. A total of 5,400 drugs were screened, generating approximately 15 million
               binary drug combinations. After further screening, the team selected the top 3 binary combinations with
               more than 75% of potential regenerative capabilities. The neuroprotective effects of these drug combinations
               were then validated in in vitro and in vivo models. This strategy elucidated the therapeutic actions of
               combinatorial drug therapy with acamprosate plus ribavirin. Most importantly, the authors demonstrated
               the discovery of repurposed drug therapies with a network-centric approach, which uses ML tools to
               validate both efficacy and mechanism of action with preclinical in vivo models.


               Additionally, large image datasets can be utilized by AI systems for rapid biomedical research. Daeschler
               et al. validated a DL model of automated segmentation and histomorphometry of myelinated peripheral
               nerves via light microscopic images . A CNN was trained for automated axon and myelin segmentation
                                              [44]
               using a dataset of light-microscopic cross-sectional images of rat nerves at various stages of axonal
               regeneration. Their CNN model demonstrated high pixel-wise accuracy for nerve fiber segmentation with
               ground truth overlap (mean ± standard deviation) of 0.93 ± 0.03 and 0.99 ± 0.01 for axons and myelin
               sheaths, respectively. Nerve fibers were identified with high sensitivity (0.99) and precision (0.97), with
               automated histomorphometry reducing analysis time to less than 2.5% of that for manual morphometry.
               Neural network-powered biomedical image analysis can significantly increase the rate of experimental nerve
               research via performance, time, and resource efficiency.


               Beyond its role in drug therapy and image processing, AI has potential applications in the direct repair of
               PNI using 3D printing and biomaterials. Nerve guidance conduits (NGCs) have been widely explored for
               the treatment of PNI. Current research on functional NGCs attempts to create microenvironments that
   50   51   52   53   54   55   56   57   58   59   60